How I Treat: Coronary Heart Disease: The Pleiotropic Effects of Statins

P. Vitulli, M. Peruzzi, G. Biondi‐Zoccai, E. Greco, A. Marullo, G. Frati
{"title":"How I Treat: Coronary Heart Disease: The Pleiotropic Effects of Statins","authors":"P. Vitulli, M. Peruzzi, G. Biondi‐Zoccai, E. Greco, A. Marullo, G. Frati","doi":"10.33590/emjcardiol/10311100","DOIUrl":null,"url":null,"abstract":"EMJ EUROPEAN MEDICAL JOURNAL CARDIOLOGY • February 2015 EMJ EUROPEAN MEDICAL JOURNAL 78 79 Cardiovascular (CV) diseases currently represent the first cause of death in industrialised countries with coronary heart disease (CHD) corresponding to the zenith of the phenomenon being responsible either for acute CV events or chronic heart failure (HF). Over 7 million people every year die from CHD, accounting for 12.8% of all deaths. Dyslipidaemias undeniably play a pivotal role in the pathogenesis and progression of atherosclerosis, and lipid lowering with statins is an essential and integral part of CHD prevention and management. Statins are the most widely prescribed drugs worldwide for lowering blood cholesterol levels. They have been used for over 20 years, and have been found to be effective, safe, and well tolerated over a broad range of patients.","PeriodicalId":284912,"journal":{"name":"EMJ Cardiology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMJ Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emjcardiol/10311100","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

EMJ EUROPEAN MEDICAL JOURNAL CARDIOLOGY • February 2015 EMJ EUROPEAN MEDICAL JOURNAL 78 79 Cardiovascular (CV) diseases currently represent the first cause of death in industrialised countries with coronary heart disease (CHD) corresponding to the zenith of the phenomenon being responsible either for acute CV events or chronic heart failure (HF). Over 7 million people every year die from CHD, accounting for 12.8% of all deaths. Dyslipidaemias undeniably play a pivotal role in the pathogenesis and progression of atherosclerosis, and lipid lowering with statins is an essential and integral part of CHD prevention and management. Statins are the most widely prescribed drugs worldwide for lowering blood cholesterol levels. They have been used for over 20 years, and have been found to be effective, safe, and well tolerated over a broad range of patients.
我如何治疗:冠心病:他汀类药物的多效作用
心血管(CV)疾病目前是工业化国家冠状动脉心脏疾病(CHD)的第一大死亡原因,与导致急性心血管事件或慢性心力衰竭(HF)的现象相对应。每年有700多万人死于冠心病,占总死亡人数的12.8%。不可否认,血脂异常在动脉粥样硬化的发病和进展中起着关键作用,他汀类药物降脂是冠心病预防和治疗的重要组成部分。他汀类药物是世界上使用最广泛的降低血液胆固醇水平的处方药。它们已经使用了20多年,并且在广泛的患者中被发现是有效、安全且耐受性良好的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信